Synopsis
Synopsis
0
KDMF
0
VMF
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Antergan
2. Cyproheptadine
3. Dihexazin
4. Periactin
5. Peritol
6. Viternum
1. 969-33-5
2. Cyproheptadine Hcl
3. Periactin Hydrochloride
4. Anarexol
5. Cipractin
6. Nuran
7. Antegan
8. Peritol
9. Periactin Syrup
10. Component Of Dronactin
11. Cyproheptadine (hydrochloride)
12. Cyproheptadine Hydrochloride Anhydrous
13. Cyproheptadiene Hydrochloride
14. 41354-29-4
15. Nsc-169911
16. Cyproheptadine Hydrochloride Sesquihydrate
17. Cyproheptadine Hydrochloride (anhydrous)
18. Cpd000058431
19. Mls000028462
20. Chebi:59695
21. 0s9323mct0
22. 4-(5h-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine Hydrochloride
23. Periactine
24. Nsc-759282
25. Smr000058431
26. 4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine Hydrochloride
27. Cyproheptadine (hydrochloride Sesquihydrate)
28. 1-methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine Hydrochloride
29. 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride
30. Periactinol (van)
31. Contrallerg
32. Kulinet
33. Kyliver
34. Sialotin
35. Vinorex
36. Istam
37. Periactinol Hydrochloride
38. Cyproheptadine Chlorhydrate
39. 4-(5h-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine Hydrochloride
40. 4-(5h-dibenzo[a,d]cyclohepten-5-ylidine)-methylpiperidine Hydrochloride
41. Cycloheptadine Hydrochloride
42. Cyproheptadine Hydrochloride Hydrate
43. Vufb3511
44. Sr-01000003077
45. Einecs 213-535-1
46. Nsc 169911
47. C21h21n.hcl
48. Unii-0s9323mct0
49. 4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine Hydrochloride
50. Ai3-26940
51. 1-methyl-4-(5-dibenzo[a,e]cycloheptatrienylidene)piperidine Hydrochloride
52. 4-(dibenzo[2,1-b:1',2'-e][7]annulen-11-ylidene)-1-methylpiperidine;hydrochloride
53. Cycloheptadine Hcl
54. Prestwick_139
55. Opera_id_383
56. Cypoheptadine Hydrochloride
57. Cyproheptadine-hydrochloride
58. Piperidine, 4-(5h-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-, Hydrochloride
59. Chembl1716
60. Schembl41842
61. Mls001077277
62. Mls001424281
63. Mls002222173
64. Regid_for_cid_13770
65. Cyproptadine Hydrochloride,(s)
66. Dtxsid5042586
67. Hy-b0366a
68. Hms1568e08
69. Hms3414j05
70. Hms3678j03
71. Pharmakon1600-01505973
72. Bcp34399
73. Cyproheptadine Hydrochloride (anh.)
74. Tox21_500246
75. Anhydrous Cyproheptadine Hydrochloride
76. Mfcd00012538
77. Nsc169911
78. Nsc759282
79. S2044
80. Akos015905305
81. Ccg-101144
82. Lp00246
83. Nc00394
84. Cyproheptadine Hydrochloride (periactin)
85. Ncgc00093708-01
86. Ncgc00093708-02
87. Ncgc00260931-01
88. Ac-15790
89. As-14697
90. Cyproheptadine Hydrochloride [who-dd]
91. Eu-0100246
92. Ft-0603147
93. Sw196450-4
94. C 6022
95. C77331
96. Wln: L C676 Byj Bu- Dt6n Dytj A1 &gh
97. Sr-01000003077-2
98. Sr-01000003077-4
99. Sr-01000003077-9
100. W-106308
101. Cyproheptadine Hydrochloride 100 Microg/ml In Methanol
102. Q27126856
103. Piperidine,d]cyclohepten-5-ylidene)-1-methyl-, Hydrochloride
104. 4-(5h-dibenzo [a,d]cyclohepten-5-ylidene)-1-methylpiperidine Hydrochloride
105. 4-(5h-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidinehydrochloride
106. 4-(5h-dibenzo[a,d]cyclohepten-5-yli Dine)-methylpiperidine Hydrochloride
107. 1-methyl-4-(2-tricyclo[9.4.0.0^{3,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine;hydrochloride
108. 1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine Hydrochloride
| Molecular Weight | 323.9 g/mol |
|---|---|
| Molecular Formula | C21H22ClN |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 323.1440774 g/mol |
| Monoisotopic Mass | 323.1440774 g/mol |
| Topological Polar Surface Area | 3.2 Ų |
| Heavy Atom Count | 23 |
| Formal Charge | 0 |
| Complexity | 423 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Cyproheptadine hydrochloride |
| PubMed Health | Cyproheptadine Hydrochloride (By mouth) |
| Drug Classes | Respiratory Agent |
| Drug Label | Cyproheptadine HCl USP, is an antihistaminic and antiserotonergic agent.Cyproheptadine hydrochloride USP is a white to slightly yellowish crystalline solid, with a molecular weight of 350.89, which is soluble in water, freely soluble in methanol, spa... |
| Active Ingredient | Cyproheptadine hydrochloride |
| Dosage Form | Tablet; Syrup |
| Route | Oral |
| Strength | 4mg; 2mg/5ml |
| Market Status | Prescription |
| Company | Lyne; Corepharma; Stason Pharms; Ivax Sub Teva Pharms; Pharm Assoc; Par Pharm |
| 2 of 2 | |
|---|---|
| Drug Name | Cyproheptadine hydrochloride |
| PubMed Health | Cyproheptadine Hydrochloride (By mouth) |
| Drug Classes | Respiratory Agent |
| Drug Label | Cyproheptadine HCl USP, is an antihistaminic and antiserotonergic agent.Cyproheptadine hydrochloride USP is a white to slightly yellowish crystalline solid, with a molecular weight of 350.89, which is soluble in water, freely soluble in methanol, spa... |
| Active Ingredient | Cyproheptadine hydrochloride |
| Dosage Form | Tablet; Syrup |
| Route | Oral |
| Strength | 4mg; 2mg/5ml |
| Market Status | Prescription |
| Company | Lyne; Corepharma; Stason Pharms; Ivax Sub Teva Pharms; Pharm Assoc; Par Pharm |
Histamine H1 Antagonists
Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood. (See all compounds classified as Histamine H1 Antagonists.)
Serotonin Antagonists
Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)
Anti-Allergic Agents
Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475) (See all compounds classified as Anti-Allergic Agents.)
Gastrointestinal Agents
Drugs used for their effects on the gastrointestinal system, as to control gastric acidity, regulate gastrointestinal motility and water flow, and improve digestion. (See all compounds classified as Gastrointestinal Agents.)
Antipruritics
Agents, usually topical, that relieve itching (pruritus). (See all compounds classified as Antipruritics.)
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 40578
Submission : 2024-09-30
Status : Active
Type : II
Date of Issue : 2025-11-12
Valid Till : 2028-07-02
Written Confirmation Number : WC-0155
Address of the Firm :
NDC Package Code : 66412-0122
Start Marketing Date : 2025-06-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Tagoor's product development expertise, backed by our comprehensive understanding of the processes, helps us offer high-quality APIs.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-04-23
Pay. Date : 2013-04-09
DMF Number : 3524
Submission : 1979-02-08
Status : Active
Type : II
Registration Number : 220MF10221
Registrant's Address : Via Bissone, 5, 20021-Baranzate, Milano, Italy
Initial Date of Registration : 2008-11-04
Latest Date of Registration :
NDC Package Code : 46438-0036
Start Marketing Date : 1980-01-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

GDUFA
DMF Review : Reviewed
Rev. Date : 2014-05-15
Pay. Date : 2012-11-26
DMF Number : 3293
Submission : 1978-09-13
Status : Active
Type : II
Registration Number : 220MF10143
Registrant's Address : Strada Rivoltana Km 6/7 20053 Rodano Milano Italy
Initial Date of Registration : 2008-06-10
Latest Date of Registration :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
Cyproheptadine Hydrochloride EP
Date of Issue : 2025-11-12
Valid Till : 2028-07-02
Written Confirmation Number : WC-0155
Address of the Firm : A-14, A-15, A-31, A-32 & A-33, M.I.D.C. Area, Chincholi, Solapur-413 255, Mahara...
Cyproheptadine Hydrochloride BP/USP/Ph.Eur
Date of Issue : 2022-08-16
Valid Till : 2025-08-13
Written Confirmation Number : WC-0229
Address of the Firm : Survey No. 270, Nawabpet Village, Shivampet Mandai, Medak District, Telangana-50...

Date of Issue : 2020-06-18
Valid Till : 2022-08-13
Written Confirmation Number : WC-0229A2
Address of the Firm : Survey No.270, Nawabpet (V), Shivampet (M), Medak District, Telangana State, Ind...

Cyproheptadine Hydrochloride IP/USP/Ph.Eur/BP
Date of Issue : 2023-04-18
Valid Till : 2026-04-17
Written Confirmation Number : WC-0555
Address of the Firm : Plot No.: 165-182, APIIC Growth Center, Thumakunta, Anantapur-515211, Andhra Pra...

Cyproheptadine Hydrochloride BP/USP/Ph.Eur.
Date of Issue : 2025-08-01
Valid Till : 2028-07-14
Written Confirmation Number : WC-0183
Address of the Firm : Unit -Il, Plot No.79, Jawaharlal Nehru Pharma City, Thanam (V), Parawada (M), An...

Cyproheptadine Hydrochloride BP/USP/Ph. Eur
Date of Issue : 2025-05-15
Valid Till : 2028-07-04
Written Confirmation Number : WC-0070
Address of the Firm : Plot No. 37/A, 38, 39A&B, Phase-l, IDA, Jeedimetla, Hyderabad, 500055, Telangana...

Cyproheptadine Hydrochloride USP/Ph.Eur./BP/IP
Date of Issue : 2024-06-12
Valid Till : 2027-05-12
Written Confirmation Number : WC-0598
Address of the Firm : Unit-V: Plot No. 24, 24A & 24B, APSEZ-DENOTIFIED Area, Rambilli(M), Atchutapuram...

Cyproheptadine Hydrochloride USP/BP/Ph.Eur
Date of Issue : 2022-06-14
Valid Till : 2025-07-04
Written Confirmation Number : WC-0070nA2
Address of the Firm : 37/A, 38, 39 A&B, PHASE-1, IDA, Jeedimetla, Hyderabad, 500 055, Telangana, India

Cyproheptadine Hydrochloride USP/BP
Date of Issue : 2021-02-12
Valid Till : 2022-07-04
Written Confirmation Number : WC-0070Amended
Address of the Firm : Unit-1, 37/A, 38, 39 A&B, PHASE-1, IDA, Jeedimetla, Hyderabad, 500 055, Telangan...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.
NDC Package Code : 66412-0122
Start Marketing Date : 2025-06-12
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 46438-0036
Start Marketing Date : 1980-01-07
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 62991-1232
Start Marketing Date : 2011-12-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...

NDC Package Code : 38779-1226
Start Marketing Date : 2014-08-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 17337-0508
Start Marketing Date : 2017-04-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 17337-0553
Start Marketing Date : 2024-09-23
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 71554-003
Start Marketing Date : 2019-04-25
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 49452-2409
Start Marketing Date : 2000-02-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT

NDC Package Code : 66577-014
Start Marketing Date : 2018-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 66577-040
Start Marketing Date : 2018-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
KT-110, a new and innovative approach based on dual receptor targeting. Study evaluates the efficacy, safety and tolerance of KT-110, a combination of 2 molecules protected by a compositional patent, on alcohol consumption in patients suffering from severe alcoholism.
Lead Product(s): Cyproheptadine Hydrochloride,Prazosin Hydrochloride
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: ECSOR
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 30, 2021

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cyproheptadine Hydrochloride,Prazosin Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : ECSOR
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : KT-110, a new and innovative approach based on dual receptor targeting. Study evaluates the efficacy, safety and tolerance of KT-110, a combination of 2 molecules protected by a compositional patent, on alcohol consumption in patients suffering from seve...
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
August 30, 2021

Details:
Remdesivir is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Lead Product(s):
Remdesivir,Imatinib Mesylate,Dexamethasone,Cenicriviroc,Icatibant Acetate,Apremilast,Dornase Alfa,Celecoxib,
Therapeutic Area: Infections and Infectious Diseases
Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous Sponsor:
University of California, San Francisco | University of Pennsylvania | Gabrail Cancer Center Research | University of Alabama at Birmingham | University of Colorado, Denver | University of Southern California | Yale University | Wake Forest University Hea
Deal Size: Inapplicable
Upfront Cash: Inapplicable
Deal Type: Inapplicable
July 27, 2020

Lead Product(s) :
Remdesivir,Imatinib Mesylate,Dexamethasone,Cenicriviroc,Icatibant Acetate,Apremilast,Dornase Alfa,Celecoxib,
Therapeutic Area :
Infections and Infectious Diseases Highest Development Status :
Phase II Partner/Sponsor/Collaborator :
University of California, San Francisco | University of Pennsylvania | Gabrail Cancer Center Research | University of Alabama at Birmingham | University of Colorado, Denver | University of Southern California | Yale University | Wake Forest University Hea Deal Size : Inapplicable Deal Type : Inapplicable
I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
Details : Remdesivir is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of COVID-19.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 27, 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Cyproheptadine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Alcoholism.
Lead Product(s): Cyproheptadine Hydrochloride,Prazosin Hydrochloride
Therapeutic Area: Psychiatry/Psychology Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Miscellaneous
Sponsor: ECSOR
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 27, 2019

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cyproheptadine Hydrochloride,Prazosin Hydrochloride
Therapeutic Area : Psychiatry/Psychology
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : ECSOR
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Cyproheptadine is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Alcoholism.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
September 27, 2019

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Cyproheptadine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Cyproheptadine Hydrochloride,Megestrol Acetate
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Severance Hospital
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 18, 2015

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cyproheptadine Hydrochloride,Megestrol Acetate
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Severance Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics and Safety Study of Apetrol ES
Details : Cyproheptadine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 18, 2015

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Cyproheptadine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Lead Product(s): Cyproheptadine Hydrochloride,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IProduct Type: Miscellaneous
Sponsor: Asan Medical Center
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 26, 2011

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Cyproheptadine Hydrochloride,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Partner/Sponsor/Collaborator : Asan Medical Center
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics and Safety Study of Apetrol ES in Healthy Male Volunteers
Details : Cyproheptadine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 26, 2011

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dibenzosuberenone (Di BENZOYL SUBERNONE) (CPH-IV)
CAS Number : 2222-33-5
End Use API : Cyproheptadine Hydrochloride
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer specializing in anti-asthmatic, anti-migraine, and anti-psychotic APIs for domestic and in...
CAS Number : 1210-35-1
End Use API : Cyproheptadine Hydrochloride
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer specializing in anti-asthmatic, anti-migraine, and anti-psychotic APIs for domestic and in...
5-(1-methylpiperidin-4-yl)5H-Dibenzo [a,d] [7] ann...
CAS Number : 3967-32-6
End Use API : Cyproheptadine Hydrochloride
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer specializing in anti-asthmatic, anti-migraine, and anti-psychotic APIs for domestic and in...
CAS Number : 5570-77-4
End Use API : Cyproheptadine Hydrochloride
About The Company : Vamsi Labs, established in 1991, is a leading Indian API manufacturer specializing in anti-asthmatic, anti-migraine, and anti-psychotic APIs for domestic and in...
CAS Number : 2222-33-5
End Use API : Cyproheptadine Hydrochloride
About The Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-g...
CAS Number : 5570-77-4
End Use API : Cyproheptadine Hydrochloride
About The Company : Tagoor Laboratories, established in 2018 and part of the Tagoor Group, provides APIs, advanced intermediates, and key starting materials for critical and high-g...
CAS Number : 2222-33-5
End Use API : Cyproheptadine Hydrochloride
About The Company : Established in 1984, R L Fine Chem Pvt. Ltd. is one of the fastest growing API companies, with a leadership position in several APIs such as antihistamines, ant...

CAS Number : 2222-33-5
End Use API : Cyproheptadine Hydrochloride
About The Company : VASUDHA PHARMA CHEM LIMITED was incorporated, as a public limited company under the Companies Act, 1956 in 1994-95 at Hyderabad in the state of Telangana, India...

CAS Number : 5570-77-4
End Use API : Cyproheptadine Hydrochloride
About The Company : VASUDHA PHARMA CHEM LIMITED was incorporated, as a public limited company under the Companies Act, 1956 in 1994-95 at Hyderabad in the state of Telangana, India...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]RLD : No
TE Code :
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 1982-01-01
Application Number : 87129
RX/OTC/DISCN : DISCN
RLD : No
TE Code :
RLD : No
TE Code : AA
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 2018-04-11
Application Number : 209172
RX/OTC/DISCN : RX
RLD : No
TE Code : AA
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 1985-02-15
Application Number : 88798
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 1982-01-01
Application Number : 85245
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 1982-01-01
Application Number : 86165
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AA
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 2016-11-29
Application Number : 206553
RX/OTC/DISCN : RX
RLD : No
TE Code : AA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code :
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 1982-01-01
Application Number : 87056
RX/OTC/DISCN : DISCN
RLD : Yes
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AA
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 2021-02-24
Application Number : 212491
RX/OTC/DISCN : RX
RLD : No
TE Code : AA

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML
Approval Date : 2021-12-21
Application Number : 205431
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Brand Name : CYPROHEPTADINE HYDROCHLORIDE
Dosage Form : TABLET;ORAL
Dosage Strength : 4MG
Approval Date : 1982-01-01
Application Number : 87284
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Periactin
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date : 1961-02-01
Application Number : 35622
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Carnitine Hydrochloride; Arginine Aspartate; Cyproheptadine Hydrochloride
Brand Name : Desarrol
Dosage Form : Solution
Dosage Strength : 50MG; 25MG; 0.2 MG
Packaging :
Approval Date : 1972-06-01
Application Number : 50242
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Arginine Aspartate; Cyproheptadine Ketoglutarate
Brand Name : Dynamogen
Dosage Form : Oral Solution
Dosage Strength : 3MG; 1G
Packaging :
Approval Date : 1977-05-01
Application Number : 53715
Regulatory Info : Authorized
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Moldova
Arginine aspartase; Cyproheptadine alfa-ketoglutarate
Brand Name : Dynamogen®
Dosage Form : Oral Solution
Dosage Strength :
Packaging :
Approval Date : 19-07-2023
Application Number :
Regulatory Info :
Registration Country : Moldova

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Suspensed
Registration Country : Spain
Cobamamide; Cyproheptadine Hydrochloride
Brand Name : Tonico Juventus
Dosage Form : Extemporanean Suspension
Dosage Strength : 1MG; 250MCG
Packaging :
Approval Date : 1970-11-01
Application Number : 49107
Regulatory Info : Suspensed
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Cancelled
Registration Country : Spain
Cobamamide; Cyproheptadine Hydrochloride
Brand Name : Covitasa Capsules
Dosage Form : Capsule
Dosage Strength :
Packaging :
Approval Date : 1969-11-01
Application Number : 48622
Regulatory Info : Cancelled
Registration Country : Spain

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Authorized
Registration Country : Spain
Carnitine Hydrochloride; Lysine Hydrochloride; Cyproheptadine Hydrochloride
Brand Name : Pranzo
Dosage Form : Oral Solution
Dosage Strength : 62.5MG; 1.25MG; 0.5MG
Packaging :
Approval Date : 1969-05-01
Application Number : 47944
Regulatory Info : Authorized
Registration Country : Spain

Regulatory Info :
Registration Country : Italy
Brand Name : Periactin
Dosage Form :
Dosage Strength : 30 Cpr 4 Mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Italy
Brand Name : Periactin
Dosage Form :
Dosage Strength : The Scir 150 Ml 0.04%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : EURO-CYPROHEPTADINE 2MG/5ML
Dosage Form : SYRUP
Dosage Strength : 2MG/5ML
Packaging : 250ML
Approval Date :
Application Number : 2466732
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : JAMP-CYPROHEPTADINE
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 2332248
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada
Brand Name : MAR-CYPROHEPTADINE
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 2533065
Regulatory Info : NON-PRESCRIPTION DRUGS
Registration Country : Canada

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : OTC
Registration Country : Canada
Brand Name : PMS-CYPROHEPTADINE HCL TAB 4MG
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging : 100/500
Approval Date :
Application Number :
Regulatory Info : OTC
Registration Country : Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Cipla-Actin
Dosage Form : TAB
Dosage Strength : 4mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : Periactin
Dosage Form : TAB
Dosage Strength : 4mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : South Africa
Brand Name : Zyactin
Dosage Form : TAB
Dosage Strength : 4mg
Packaging : 30X1mg
Approval Date :
Application Number :
Regulatory Info : Generic
Registration Country : South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Regulatory Info :
Registration Country : India
Brand Name : Cyproheptadine Hydroch...
Dosage Form : DC Granules
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
Packaging :
Regulatory Info :
Dosage : DC Granules
Dosage Strength : 4MG
Brand Name : Cyproheptadine Hydroch...
Approval Date :
Application Number :
Registration Country : India
Regulatory Info :
Registration Country : India
Brand Name : Cyproheptadine Hydroch...
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 4MG
Brand Name : Cyproheptadine Hydroch...
Approval Date :
Application Number :
Registration Country : India
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Iran
Brand Name :
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 4MG
Brand Name :
Approval Date :
Application Number :
Registration Country : Iran

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name : Goodvita
Dosage Form : Capsule
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Capsule
Dosage Strength : 4MG
Brand Name : Goodvita
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name : Hungry Up
Dosage Form : Syrup
Dosage Strength : 2MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Syrup
Dosage Strength : 2MG/5ML
Brand Name : Hungry Up
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name : Siiper Pepti
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 4MG
Brand Name : Siiper Pepti
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info : Generic
Registration Country : India
Brand Name :
Dosage Form : TABLET
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number : 40644
Regulatory Info : Generic
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info : Generic
Dosage : TABLET
Dosage Strength : 4MG
Brand Name :
Approval Date :
Application Number : 40644
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 4MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 4MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : Turkey
Brand Name :
Dosage Form : Oral Solution
Dosage Strength : 2MG/5ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Oral Solution
Dosage Strength : 2MG/5ML
Brand Name :
Approval Date :
Application Number :
Registration Country : Turkey

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 2MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Packaging :
Regulatory Info :
Dosage : Tablet
Dosage Strength : 2MG
Brand Name :
Approval Date :
Application Number :
Registration Country : India

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Dosage Form : Tablet
Grade : Oral
Application : Controlled & Modified Release
Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.
Pharmacopoeia Ref : NA
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : CS90 is a directly compressible calcium carbonate with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-175 µm, Tapped Density: 0.85
Ingredient(s) : Calcium Carbonate Excipient
Dosage Form : Tablet
Grade : Oral
Application : Taste Masking
Excipient Details : MS90 is a directly compressible magnesium hydroxide with starch used for chewable tablets due to its smooth mouthfeel and creamy texture.
Pharmacopoeia Ref : NA
Technical Specs : PSD D50: 150-170 µm, Tapped Density: 0.80
Ingredient(s) : Magnesium Hydroxide Excipient
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : AceCel is suitable for majority of the directly compressible actives, combines good flow and high compressibility.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Dosage Form : Tablet
Grade : Oral
Category : Direct Compression, Fillers, Diluents & Binders, Granulation
Application : Direct Compression, Fillers, Diluents & Binders, Granulation
Excipient Details : HiCel acts as a strong dry binder. It facilitates low tablet friability & promotes rapid tablet disintegration.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Microcrystalline Cellulose Excipients
Grade : Oral
Category : Disintegrants & Superdisintegrants, Granulation, Lubricants & Glidants
Application : Disintegrants & Superdisintegrants, Granulation, Lubricants & Glidants
Application : Fillers, Diluents & Binders, Granulation
Excipient Details : Fully Pregel Starch Corn is used as a binder in wet granulation in the manufacturing of tablets.
Brand Name : Sheffield™ Monohydrate 313
Application : Granulation
Excipient Details : Wet Granulation & Capsule Filling
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Application : Fillers, Diluents & Binders, Granulation
Pharmacopoeia Ref : Conforms to USP-NF, Ph.Eur., J...
Technical Specs : Density- Tapped density- 857 g/l, Bulk density- 589 g/l; Particle...
Ingredient(s) : Lactose Monohydrate
Excipients Web Link
Application : Fillers, Diluents & Binders, Granulation
Pharmacopoeia Ref : EP./USP.NF
Technical Specs : NA
Ingredient(s) : Microcrystalline Cellulose Excipients
Brand Name : Sheffield™ Monohydrate 310
Application : Granulation
Excipient Details : Wet Granulation & Capsule Filling
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Brand Name : Sheffield™ Monohydrate 312
Application : Granulation
Excipient Details : Wet Granulation & Capsule Filling
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Application : Direct Compression, Granulation
Excipient Details : HiCellac is used in direct compression & dry granulation suitable for low dose formulations where API content uniformity is critical.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Lactose Monohydrate
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgels
Grade : Parenteral, Oral, Topical
Category : Film Formers & Plasticizers, Parenteral, Thickeners and Stabilizers, Topical
Dosage Form : Capsule, Cream / Lotion / Ointment
Grade : Topical and Oral
Category : Film Formers & Plasticizers, Topical
Application : Film Formers & Plasticizers, Topical
Excipients Web Link
Dosage Form : Capsule, Emulsion, Softgel Capsule, Solution, Tablet, Topical Film
Grade : Not Available
Category : Film Formers & Plasticizers, Solubilizers, Topical
Application : Film Formers & Plasticizers, Solubilizers, Topical
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Grade : Oral
Category : Coating Systems & Additives, Film Formers & Plasticizers
Application : Coating Systems & Additives, Film Formers & Plasticizers
Excipient Details : Ready mix Film coating system for moisture sensitive APIs
Pharmacopoeia Ref : USP, EP, JP; Having US-DMF
Technical Specs : Moisture barrier film coating system
Ingredient(s) : Hydroxypropyl Methyl Cellulose
Dosage Form : Cream / Lotion / Ointment, Gel, Solution
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Topical
Application : Emulsifying Agents, Solubilizers, Topical
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Capsule, Emulsion, Softgel Capsule, Solution, Tablet, Topical Film
Grade : Not Available
Category : Film Formers & Plasticizers, Solubilizers, Topical
Application : Film Formers & Plasticizers, Solubilizers, Topical
Excipient Details : Liquid plasticizer with high ADI, hydrophilic solvent & humectant in emulsions, skin penetration enhancer in topical formulaitons.
Pharmacopoeia Ref : Ph. Eur., JP, FCC, USP
Technical Specs : Not Available
Ingredient(s) : Propylene Glycol
Dosage Form : Cream / Lotion / Ointment, Gel, Solution
Grade : Oral, Topical
Category : Emulsifying Agents, Solubilizers, Topical
Application : Emulsifying Agents, Solubilizers, Topical
Excipient Details : Hydrosol 50 is used as a solubilizer and emulsifying agent in oral and topical liquid and semi-solid dosage forms.
Pharmacopoeia Ref : USP/NF
Technical Specs : N/A
Ingredient(s) : Polyoxyl 40 Hydrogenated Castor Oil
Dosage Form : Cream / Lotion / Ointment, Tablet
Grade : Oral
Category : Emulsifying Agents, Lubricants & Glidants, Thickeners and Stabilizers
Application : Emulsifying Agents, Lubricants & Glidants, Thickeners and Stabilizers
Dosage Form : Tablet, Emulsion, Suspension
Grade : Oral
Category : Co-Processed Excipients, Fillers, Diluents & Binders, Rheology Modifiers
Application : Co-Processed Excipients, Fillers, Diluents & Binders, Rheology Modifiers
Excipient Details : HiCel MCG is use in oral suspensions as a stabilizer. It is a good binder for tablets & excellent thickener as well.
Pharmacopoeia Ref : Not Available
Technical Specs : Not Available
Ingredient(s) : Carboxymethyl Cellulose Sodium
https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205431

24 May 2019
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212423

16 Apr 2019
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206676

20 Oct 2018
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209108
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209172

17 Jul 2017
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203191
Global Sales Information
Company : Amneal Pharmace
CyproHEPtadine HCl
Drug Cost (USD) : 899,483
Year : 2023
Prescribers : 14642
Prescriptions : 34496

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Apnar Pharma, L
CyproHEPtadine HCl
Drug Cost (USD) : 2,141
Year : 2023
Prescribers : 66
Prescriptions : 90

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Bayshore Pharma
CyproHEPtadine HCl
Drug Cost (USD) : 519,141
Year : 2023
Prescribers : 5838
Prescriptions : 13532

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Breckenridge
CyproHEPtadine HCl
Drug Cost (USD) : 101,553
Year : 2023
Prescribers : 1472
Prescriptions : 3350

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Chartwell Rx Ll
CyproHEPtadine HCl
Drug Cost (USD) : 1,024
Year : 2023
Prescribers : 11
Prescriptions : 15

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Ingenus Pharmac
CyproHEPtadine HCl
Drug Cost (USD) : 318,884
Year : 2023
Prescribers : 4041
Prescriptions : 10016

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Lannett Co. Inc
CyproHEPtadine HCl
Drug Cost (USD) : 9,127
Year : 2023
Prescribers : 160
Prescriptions : 284

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Marlex Pharm.
CyproHEPtadine HCl
Drug Cost (USD) : 2,194
Year : 2023
Prescribers : 155
Prescriptions : 281

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Quagen Pharmace
CyproHEPtadine HCl
Drug Cost (USD) : 483,853
Year : 2023
Prescribers : 6751
Prescriptions : 16046

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Company : Rising Pharm
CyproHEPtadine HCl
Drug Cost (USD) : 148,030
Year : 2023
Prescribers : 1870
Prescriptions : 4301

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Dosage Form : SYRUP;ORAL
Dosage Strength : 2MG/5ML
Price Per Pack :
Published in :
Country : USA
RX/OTC/DISCN : RX

AVANTGARDE (Gruppo SIGMA-TAU)
Dosage Form :
Dosage Strength : 30 Cpr 4 Mg
Price Per Pack (Euro) : 5
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
AVANTGARDE (Gruppo SIGMA-TAU)
Dosage Form :
Dosage Strength : The Scir 150 Ml 0.04%
Price Per Pack (Euro) : 5
Published in :
Country : Italy
RX/OTC/DISCN : Class C

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Reply
16 Jan 2026
Reply
18 Dec 2025
Reply
08 Dec 2025
Reply
27 Sep 2024
Reply
02 Sep 2024
Reply
20 May 2024
Reply
21 Nov 2023
Reply
14 Jul 2023
Reply
29 Sep 2022
Reply
23 Mar 2022
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Reply
07 Sep 2022

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.
Cyproheptadine Related Compound A
CAS Number :
Quantity Per Vial :
Sale Unit :
Price : $707.00
Details :
Monograph : PHR2685-50MG
Storage : +2°C to +8°C
Code/Batch No :
Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.
CAS Number :
Quantity Per Vial :
Sale Unit :
Price : $211.00
Details :
Monograph : PHR2684-500MG
Storage : +2°C to +30°C
Code/Batch No :
CAS Number :
Quantity Per Vial :
Sale Unit :
Price : $707.00
Details :
Monograph : PHR2685-50MG
Storage : +2?C to +8?C
Code/Batch No :

CAS Number :
Quantity Per Vial :
Sale Unit :
Price : $211.00
Details :
Monograph : PHR2684-500MG
Storage : +2?C to +30?C
Code/Batch No :

Cyproheptadine Related Compound A (40 mg) (5H...
CAS Number : 256-81-5
Quantity Per Vial : 40
Sale Unit : mg
Price : $835.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1161010 / R128R0

Cyproheptadine Related Compound C (25 mg) (5-...
CAS Number : 3967-32-6
Quantity Per Vial : 25
Sale Unit : mg
Price : $877.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1161032 / R078J0

Cyproheptadine Hydrochloride (500 mg)
CAS Number : 41354-29-4
Quantity Per Vial : 500
Sale Unit : mg
Price : $245.00
Details : Material Origin- Chemical Synthesis; USMCA- N...
Monograph :
Storage :
Code/Batch No : Catalog #1161000 / R072P0

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
41
PharmaCompass offers a list of Cyproheptadine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Cyproheptadine Hydrochloride manufacturer or Cyproheptadine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Cyproheptadine Hydrochloride manufacturer or Cyproheptadine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Cyproheptadine Hydrochloride API Price utilized in the formulation of products. Cyproheptadine Hydrochloride API Price is not always fixed or binding as the Cyproheptadine Hydrochloride Price is obtained through a variety of data sources. The Cyproheptadine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Cyproheptadine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cyproheptadine, including repackagers and relabelers. The FDA regulates Cyproheptadine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cyproheptadine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cyproheptadine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cyproheptadine supplier is an individual or a company that provides Cyproheptadine active pharmaceutical ingredient (API) or Cyproheptadine finished formulations upon request. The Cyproheptadine suppliers may include Cyproheptadine API manufacturers, exporters, distributors and traders.
click here to find a list of Cyproheptadine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cyproheptadine DMF (Drug Master File) is a document detailing the whole manufacturing process of Cyproheptadine active pharmaceutical ingredient (API) in detail. Different forms of Cyproheptadine DMFs exist exist since differing nations have different regulations, such as Cyproheptadine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cyproheptadine DMF submitted to regulatory agencies in the US is known as a USDMF. Cyproheptadine USDMF includes data on Cyproheptadine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cyproheptadine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cyproheptadine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Cyproheptadine Drug Master File in Japan (Cyproheptadine JDMF) empowers Cyproheptadine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Cyproheptadine JDMF during the approval evaluation for pharmaceutical products. At the time of Cyproheptadine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Cyproheptadine suppliers with JDMF on PharmaCompass.
A Cyproheptadine CEP of the European Pharmacopoeia monograph is often referred to as a Cyproheptadine Certificate of Suitability (COS). The purpose of a Cyproheptadine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cyproheptadine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cyproheptadine to their clients by showing that a Cyproheptadine CEP has been issued for it. The manufacturer submits a Cyproheptadine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cyproheptadine CEP holder for the record. Additionally, the data presented in the Cyproheptadine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cyproheptadine DMF.
A Cyproheptadine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cyproheptadine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cyproheptadine suppliers with CEP (COS) on PharmaCompass.
A Cyproheptadine written confirmation (Cyproheptadine WC) is an official document issued by a regulatory agency to a Cyproheptadine manufacturer, verifying that the manufacturing facility of a Cyproheptadine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cyproheptadine APIs or Cyproheptadine finished pharmaceutical products to another nation, regulatory agencies frequently require a Cyproheptadine WC (written confirmation) as part of the regulatory process.
click here to find a list of Cyproheptadine suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cyproheptadine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cyproheptadine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cyproheptadine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cyproheptadine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cyproheptadine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cyproheptadine suppliers with NDC on PharmaCompass.
Cyproheptadine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cyproheptadine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cyproheptadine GMP manufacturer or Cyproheptadine GMP API supplier for your needs.
A Cyproheptadine CoA (Certificate of Analysis) is a formal document that attests to Cyproheptadine's compliance with Cyproheptadine specifications and serves as a tool for batch-level quality control.
Cyproheptadine CoA mostly includes findings from lab analyses of a specific batch. For each Cyproheptadine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cyproheptadine may be tested according to a variety of international standards, such as European Pharmacopoeia (Cyproheptadine EP), Cyproheptadine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cyproheptadine USP).